about
Mutator pathways unleashed by epigenetic silencing in human cancerUbiquitination regulates PTEN nuclear import and tumor suppressionThe Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of CancerHelicobacter pylori and colorectal neoplasia: Is there a causal link?Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Epigenetic inactivation of the premature aging Werner syndrome gene in human cancerProspective health care: the second transformation of medicineCanVar: A resource for sharing germline variation in cancer patients.Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenThe profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study.Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis.Clinical management of hereditary breast cancer syndromes.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Regulation of gross chromosomal rearrangements by ubiquitin and SUMO ligases in Saccharomyces cerevisiae.Clinical application of genetics in management of colorectal cancer.Identification of rare germline copy number variations over-represented in five human cancer types.The signatures of autozygosity among patients with colorectal cancer.Oxygen metabolism and reactive oxygen species cause chromosomal rearrangements and cell deathReliably Detecting Clinically Important Variants Requires Both Combined Variant Calls and Optimized Filtering Strategies.DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers StudyPrevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.Tissue-specific tumorigenesis: context matters.BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?Pitfalls and caveats in BRCA sequencing.The balance between heritable and environmental aetiology of human disease.A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancerGenetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.The pleiotropic phenotype of Apc mutations in the mouse: allele specificity and effects of the genetic background.The latent class twin method.HOXB13 and other high penetrant genes for prostate cancer.The genomics of colorectal cancer: state of the art.Copy number variations and cancer.Multidisciplinary surgical management of Cowden syndrome: Report of a case.Age of onset in familial cancer.Exome sequencing reveals germline gain-of-function EGFR mutation in an adult with Lhermitte-Duclos disease.Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome.
P2860
Q22242850-B4D6CD02-38D5-421A-A9EA-284EF2A7D68FQ24292946-2F43E41A-8643-43C6-8060-1AAA137C79A5Q26767214-850DE7FF-50DF-4A98-8B05-5CE0494A4765Q26774668-261AE10B-09F0-4E1E-B017-17F679B1D0D1Q28085485-B9D0A141-433F-47FA-84DD-4C459E55CE87Q28242111-E1CD2986-AEDF-40E1-9862-AA3686514EC9Q28300742-579CFBBF-2288-497F-94D3-A817C67D41DBQ30490732-8F1496CE-8276-4262-9CBF-867B4B7B46BEQ33576170-C3942D4D-473B-416A-B47D-B6602B9F1D75Q33615771-1BFC6301-36B9-4E99-BDA1-93F381A46207Q33799599-AFD1CE7D-F01A-449F-8FC9-C72C8FCBA1D1Q33916338-4F161F4C-8B3F-49D5-B3D3-7E41AF6ECB62Q34133663-8658096A-EF3F-4877-A815-888D09665C68Q34167563-E18FF9DF-1562-4766-ADDC-121487080FFBQ34294432-6C336CC2-AFAB-4ED1-B683-EC52957B22F0Q34353641-03415D68-0A2E-49BA-B5FC-2A9409DAAC62Q34378719-6701E515-B0DC-4DFB-85B0-17ACABF828A5Q35238058-B95D1B7D-64F1-49FB-8A28-26C21775640CQ35247248-177AA33F-9A86-46A0-B2DA-CCB1D45C3088Q35834419-2CC40EA9-6F58-4FB2-B002-75F6E708FF3FQ35850909-ABADA04D-8A81-42AC-8467-97718EBCEEBAQ35881338-85C87C02-8814-4B57-8BAC-D0A5363A1FC2Q35892049-417A571C-E5BA-4BD9-BD7D-5AF983A63EDCQ36070055-8C8B4654-8303-427A-B148-3DAA3E608066Q36296335-AE84E6CA-EE16-401C-B10F-9D1922009708Q36384018-AA187A54-108D-4696-8139-AC009A883419Q36429534-26162825-A4FE-4076-AFE7-735BC3676922Q36529399-B039C7F7-F9F7-4FAF-8AAB-5933CBDEB933Q36670492-684AAF41-5BBF-407E-8350-63B13BFA1860Q36821830-60D1807E-9AB9-4450-B224-6127931642D7Q36843211-F20CCFE3-4681-472B-835D-46742A7891D5Q36873796-6B760455-5FF4-4105-BD39-C040BFE809BEQ37083702-0A786BC3-874F-48EF-846E-CFEF659D8CE0Q37113171-F38C8AB9-F598-42AF-AAFF-709E273C7989Q37172151-77D2CC81-F4C3-4F58-87E9-EC614472FB11Q37245547-6F9DA816-7BAC-4C5D-8AAE-D9509AFA37ECQ37302554-2EDBE3B6-88F5-4B34-A3C0-D41B56F0C672Q37321949-65948B38-05AB-4D70-920E-B0B86E6F979BQ37416668-445EF601-F73D-41CD-A1F3-87DD48F5B6EEQ37694831-5EEAC7B9-895A-4D8D-BD60-1EF42D4DDA10
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Highly penetrant hereditary cancer syndromes.
@ast
Highly penetrant hereditary cancer syndromes.
@en
type
label
Highly penetrant hereditary cancer syndromes.
@ast
Highly penetrant hereditary cancer syndromes.
@en
prefLabel
Highly penetrant hereditary cancer syndromes.
@ast
Highly penetrant hereditary cancer syndromes.
@en
P356
P1433
P1476
Highly penetrant hereditary cancer syndromes
@en
P2093
Kevin Sweet
Rebecca Nagy
P2888
P304
P356
10.1038/SJ.ONC.1207714
P407
P50
P577
2004-08-01T00:00:00Z